Introduction {#S0001}
============

Colistin is the last resort for the treatment of infections caused by multidrug-resistant bacteria, particularly the carbapenem-resistant microorganisms.[@CIT0001],[@CIT0002] However, the mobile colistin-resistan﻿t gene *mcr-1*, was first reported in the *Enterobacteriaceae* by Liu et al^3^ in 2015, which led the *mcr-1* carried bacteria resistant to colistin. Since then, *mcr-1* or the *mcr* gene family-carrying bacteria have be﻿en reported in different species (such as *E. coli, klebsiella pneumoniae, Acinetobacter, Pseudomonas* and other gram-negative bacteria) isolated from food, animals, the environment and clinical samples worldwide.[@CIT0004]--[@CIT0006] To our knowledge, co-carrie﻿rs of the colistin-resistan﻿t gene *mcr* and carbapenemase-resistan﻿t genes (*bla*~KPC~, *bla*~NDM~, *bla*~IMP~, and *bla*~VIM~), microorganisms have potentially evolved into extensively drug-resistant or pan-drug-resistant isolates. Infections caused by these clinical isolates co-harboring the colistin-resistan﻿t gene (*mcr-1*) and carbapenem-resistan﻿t genes (*bla*~KPC~, *bla*~NDM~, *bla*~IMP~, and *bla*~VIM~) pose a serious threat because the antibiotic options would be much fewer.[@CIT0004],[@CIT0007],[@CIT0008] *Aeromonas* species, one kind of the gram-negative bacteria, was identified in the 1980s as an enteric pathogen which can lead to severe diarrhea.[@CIT0009] In addition, the carbapenem-resistant and/or colistin-resistan﻿t *Aeromonas* species strains have been reported increasingly in recent years to pose a serious threat in infection control.[@CIT0010]--[@CIT0012] In this study, we recovered a colistin and carbapenem﻿-resistant *Aeromonas* strain from the diarrhea sample of a 45-year-old male patient with acute diarrhea in the affiliated hospital of Southwest Medical University, and the genomic information of this strain was characterized to gain insight into further infection control.

Materials and Methods {#S0002}
=====================

Isolation and Identification of *Aeromonas caviae* SCAc2001 {#S0002-S2001}
-----------------------------------------------------------

*A. caviae* SCAc2001 was recovered from the diarrhea sample of a 45-year-old male patient with acute diarrhea in a hospital in Sichuan, China, in May, 2019. It was identified as *Aeromonas caviae* using the Vitek-2 compact system (bioMérieux, Marcy-l'Étoile, France). The presence of the acquired carbapenemase genes (*bla*~KPC~, *bla*~NDM~, *bla*~GES~, *bla*~IMP~ and *bla*~VIM~) and *mcr* genes in SCAc2001 was determined by PCR amplification as described previously.[@CIT0013]--[@CIT0015]

Antimicrobial Susceptibility Testing {#S0002-S2002}
------------------------------------

In vitro susceptibility tests of *A. caviae* SCAc2001 against 17 antimicrobial agents (Solarbio, China) including meropenem, imipenem, cefepime, cefotaxime, ceftazidime, piperacillin-tazobactam, amoxicillin-clavulanic acid, gentamicin, amikacin, aztreonam, erythromycin, chloramphenicol, colistin, tigecycline, fosfomycin and ciprofloxacin and trimethoprim-sulfamethoxazole determined by broth microdilution method according to the recommendations of the Clinical and Laboratory Standards Institute (CLSI 2013, M100-S23), and the breakpoints of colistin were interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) ([<http://www.eucast.org/>]{.ul}); *E.coli* J53 was used as quality control.

Genome Sequencing and Analysis {#S0002-S2003}
------------------------------

The genomic DNA of *A. caviae* SCAc2001 was extracted using the Axygen^®^ DNA Gel Extraction Kits (Axygen, People\'s Republic of China) according to the manufacturer's protocol. Purified DNA was subjected to whole genomic sequencing on the Illumina system with the 150-bp paired-end approach and \>180× coverage (Novogene, People\'s Republic of China). The reads were assembled using the software SOAP denovo (version 2.04).[@CIT0016] Gene prediction was performed with GeneMarkS (version 4.17).[@CIT0017] Gene annotation was achieved using the NCBI Prokaryotic Genome Annotation Pipeline. The pairwise alignment was performed by blastn search ([<http://blast.ncbi.nlm.nih.gov/Blast.cgi>]{.ul}). The resistome was identified using ResFinder ([<https://cge.cbs.dtu.dk/services/ResFinder/>]{.ul})[@CIT0018] (minimum threshold for identity, 80%; minimum coverage, 60%) and Comprehensive Antibiotic Resistance Database (CARD). The virulence factors were identified by the VFanalyzer ([<http://www.mgc.ac.cn/VFs/main.htm>]{.ul}).The pathogen--﻿host ﻿interactions (PHI) genes were identified by compar﻿ison with the ﻿pathogen--﻿host ﻿interactions database (minimum threshold for identity, 80%).[@CIT0019] To determine the phylogenetic groups of the *A. caviae* SCAc2001 strain, the phylogenetic tree was constructed by aligning the core genome of *A. caviae* SCAc2001 strain with other representative *A. caviae* strains available in the genbank ([Table 1](#T0001){ref-type="table"}). ﻿All the sequences were aligned using Mugsy and thereafter a maximum-likelihood phylogeny tree was generated using RAxML version 8 and MEGA7.0.[@CIT0020]--[@CIT0022] The genomic island sequences were predicted based on three different genomic islands (GIs) prediction softwares (IslandPATH-DIMOB, IslandPick, and SIGI-HMM)[@CIT0023]--[@CIT0025] and the prophages were predicted by using phiSpy.[@CIT0026] The secondary metabolism products coding clusters were identified by the antiSMASH.[@CIT0027]Table 1The Details of the Representative *A. Caviae* Strains Downloaded from GenbankIsolateAccess NumberCountrySamplesResistance Genes^a^GSH8M-1 chromosomes and plasmids genomeAP019195.1JapanWastewater*bla*~MOX-12~, *bla*~OXA-780~, mcr-3.18, *bla~OXA-669,~ aac(6′)‐Ia, aadA2, sul1*, *bla*~KPC-2~, *mph(A)*WCW1-2 chromosomes genomeCP039832.1People\'s Republic of\
ChinaSewage*bla*~MOX-5~, *bla*~OXA-427~, *catB3, cmlA1, floR, aac(6ʹ)-Ib-cr, qnrVC4, sul1, aac(6ʹ)-Ib3, aadA1, aph(3ʹ')-Ib, aph(3ʹ)-Ia, aph(6)-Id, dfrA14, dfrB4, bla*~OXA-10~, *tet(X4)*T25-39 chromosomes genomeCP025706People\'s Republic of\
ChinaWastewater*bla*~MOX-6~, *bla*~OXA-427~R25-2 chromosomes genomeCP025777.1People\'s Republic of\
ChinaWastewater*bla*~MOX-6~, *bla*~OXA-427~, *aph(3ʹ')-Ib, aph(6)-Id, tet(31), sul2, floR*NCTC12244 Chromosomes genomeLS483441.1UKN*bla*~MOX-6~, *bla*~OXA-427~Draft genome ZJ17-2NXBR00000000.1People\'s Republic of\
ChinaRiver water*bla*~MOX-6~, *bla*~OXA-427~, *mcr-3, cat, tet(A), aadA1, sul1*Draft genome A23LFXO00000000.1People\'s Republic of\
ChinaChicken sample*bla*~MOX-6~, *bla*~OXA-427~, *catB3, mph(A)*, *bla*~OXA-2~, *bla*~PER-3~, *aadA1b, aadA16, ac(6ʹ)-Ib-Hangzhou, aac(6ʹ)-Ib-cr, sul1*Draft genome ZJ33-3NXBW00000000.1People\'s Republic of\
ChinaHuman rectal swab*bla*~MOX-6~, *bla*~OXA-427~, *tet(A), mcr-3, cat, aadA1, sul1*Draft genome AK245JAAALU000000000.1USALake water*bla*~MOX-6~Draft genome Sch29CAAKNG000000000.1UKGastroenteritis samples*bla*~MOX-4~, *bla*~OXA-427~,Draft genome L12JWJP00000000.1MalaysiaLake water*bla*~MOX-5~, *mcr-3.15*Draft genome TCO22NMSG00000000.1USAGut samples*bla*~MOX-6~, *bla*~OXA-427~, *tetE, mcr3.12, mcr-3.15, aph(3ʹ)-Ia, mph(A)*Draft genome strain DVZQB00000000.1South AfricaSeawater*bla*~MOX-6~, *bla*~OXA-427~,Draft genome strain CH129MDSD00000000.1BraziSeawater*bla*~MOX-6~Draft genome strain CHZ306MDSC00000000.1BraziSeawater*bla*~MOX-6~, *bla*~OXA-427~, tetEDraft genome strain ScAc2001WUTZ00000000.1 (In this study)People\'s Republic of\
ChinaHuman sample*bla*~MOX-6~, *bla*~OXA-427~, *aac(6ʹ)-Ib3, aadA1, bla*~OXA-10~, *catB3, sul1, mcr-3, dfrA5, bla*~CTX-M-14~, *bla*~KPC-2~, *bla*~TEM-150~, *bla*~VEB-3~[^2][^3]

Results and Discussion {#S0003}
======================

Characteristics of the Isolate SCAc2001 {#S0003-S2001}
---------------------------------------

A carbapenem-resistant gene *bla*~KPC~ and a colistin-resistan﻿t gene *mcr-3.3* co-carried ﻿by *A. caviae* strain SCAc2001 was isolated and identified by the Vitek-2 compact system and resistance genes PCR detection from the diarrhea sample. The results of antimicrobial susceptibility testing showed that *A. cavia*e SCAc2001 strain was resistant to meropenem, imipenem, cefepime, cefotaxime, ceftazidime, piperacillin-tazobactam, amoxicillin-clavulanic acid, gentamicin, amikacin, aztreonam, erythromycin, chloramphenicol, colistin, ciprofloxacin and trimethoprim-sulfamethoxazole and sensitive to the tigecycline and fosfomycin. While the negative control *E.coli* J53 was sensitive to all the test antibiotics. To the best of our knowledge, the *Aeromonas species* isolated from environmental water samples received widespread attention several years ago. However, there ha﻿ve been more reports of the *Aeromonas* species infection in humans worldwide in recent years﻿,[@CIT0028],[@CIT0029] ﻿because the *Aeromonas* species have always ﻿been identified a﻿s enteric pathogens which can lead to severe diarrhoea.[@CIT0009] Unfortunately, what's more serious is that the carbapenem-resistant and/or colistin-resistan﻿t strains ﻿produce emergenc﻿ies in some countries and pose a serious threat to infectious diseases control and clinical treatment.[@CIT0030],[@CIT0031]

Draft Genome Characterization of SCAc2001 and Phylogenetic Analysis {#S0003-S2002}
-------------------------------------------------------------------

A total of 1 Gigabases pairs (Gbp) of raw genome data was obtained from the Illumina system. Thereafter, we got about 800 million bases (Mbp) of clean data from the 1Gbp raw genome data by using the readfq (version 10). The 800Mbp clean data was assembled into a 340 scaffolds draft genome sequence of *Aeromonas caviae* strain SCAc2001 by the SOAP denovo, with a G+C content of 61.09%, for a total of 4487370bp. We predicted 4265 protein-coding sequences (CDS) in the draft genome. The genome encodes 103 tRNAs and 14 rRNAs, which contains ﻿five copies of the 5S rRNA gene, ﻿five copies of the 16S rRNA gene, and ﻿four copies of the 23S rRNA genes. The core genome-based phylogenetic analysis showed that the *A. caviae* SCAc2001 strain was highly similar to the *A. caviae* strain R25-2 (Genbank accession number: CP025777.1) and T25-39 (Genbank accession number: CP025706), but distant from the clade grouped by the *mcr-3* carrying strain ZJ33-3 (NXBW00000000.1) and ZJ17-2 (NXBR00000000.1), and the *mcr-3* and *bla*~KPC-2~ co-carried strain GSH8M-1 (AP019195.1)[@CIT0032] ([Figure 1](#F0001){ref-type="fig"}).Figure 1The phylogenetic tree was constructed by aligning the core genome of *Aeromonas caviae* SCAc2001 strain with 15 other representative *A. caviae* strains.

Identification of the Resistance Genes, Virulence Factors and PHI Genes {#S0003-S2003}
-----------------------------------------------------------------------

A total of 13 antibiotic drug resistance genes including the β-lactams (*bla*~KPC~, *bla*~CTX-M-14~, *bla*~TEM-1~, *bla*~OXA-10~, *bla*~OXA-427~, *bla*~VEB-3~ and *bla*~MOX-6~), aminoglycosides (*aadA1*), fluoroquinolones (*aac(6ʹ)-Ib-cr*), phenicol resistance (*catB3*), sulfonamide (*sul1*) and trimethoprim (*dfrA5*) and colistin resistance gene (*mcr-3.3*) were detected in the genome of *Aeromonas caviae* strain ScAc2001c ([Table 2](#T0002){ref-type="table"}). To the best of our knowledge, many reports are show﻿ing that the multi-drug-resistant *Aeromonas*﻿ species have been isolated from clinical, animal, food, and environmental water samples ([Table 1](#T0001){ref-type="table"}). These isolates carried m﻿any more types of antibiotic resistance genes, especially the co-carried carbapenem- and colistin- resistance gene may be a huge risk for infectio﻿us disease control. Also, as show﻿n in [Table 3](#T0003){ref-type="table"}, *Aeromonas caviae* strain ScAc2001 carrie﻿s 54 putative virulence factors including type IV pilus, fimbria, flagellarthe and hemolysin A. What's more, we also identified 12 PHI genes including *csrA, lrp, crp, iscU, arcA, metJ, pykF, lon, dksA, fur, greB* and *hfq* from the genome ([Table 4](#T0004){ref-type="table"}). It proved that these PHI genes are associated with diseases such as diarrheal, meningitis and urinary tract infections.[@CIT0033] Th﻿ese results indicate the emergence of the co-location of a large number of resistance genes, a variety of virulence factors, and the PHI genes carrying *Aeromonas caviae* ScAc2001-like strain is a serious issue for public health.Table 2Distribution of the Resistance Genes in *Aeromonas caviae* SCAc2001Resistance GeneIdentity(%)Query/LengthScaffoldPosition in ScaffoldPredicted PhenotypeAccession Numberaac(6ʹ)-Ib3100555/555Scaffold2312433-2987Fluoroquinolone and aminoglycoside resistanceX60321aadA1100792/792Scaffold23129-820Aminoglycoside resistanceJQ414041*bla*~OXA-10~100801/801Scaffold231837-1637Beta-lactam resistance Alternate name; PSE-2J03427catB3100633/633Scaffold2311706-2338Phenicol resistanceU13880sul1100840/840Scaffold31025-864Sulphonamide resistanceU12338*mcr-3.3*1001623/1623Scaffold2161393-3015Polymyxin resistanceMF495680*dfrA5*100474/474Scaffold2581177-1650Trimethoprim resistanceX12868*bla*~CTX-M-14~100876/876Scaffold1803068-3943Beta-lactam resistanceAF252622*bla*~KPC-2~100882/882Scaffold7215,640-6521Beta-lactam resistanceAY034847*bla*~MOX-6~97.831153/1152Scaffold12810,749--11,900Beta-lactam resistance AmpC-typeGQ152601*bla*~OXA-427~86.43796/795Scaffold1655530--6324Beta-lactam resistanceKX827604*bla*~TEM-150~99.82570/861Scaffold7214,849--15,418Beta-lactam resistanceAM183304*bla*~VEB-3~100900/900Scaffold240750-1649Beta-lactam resistanceAY536519 Table 3Distribution of the Virulence Factors in *Aeromonas caviae* Strain SCAc2001^a^Virulence FactorScaffoldPosition in ScaffoldIdentity(%)Characteristic*tppE*Scaffold1420,853-21,35699.4Type IV pilus pseudopilin*tppB*Scaffold1420,443-20,85699.3Type IV pilus modification protein PilV*tppA*Scaffold1415,090-15,49199.2Type IV pilin*tapY1*Scaffold1415,500--18,85399.1Type IV pilus biogenesis protein*cheW-2*Scaffold65270--75898.1Chemotaxis protein CheW*pomA2*Scaffold1820,514--21,24597.9Chemotaxis protein PomA*hlyA*Scaffold9611,532--12,85197.5Hemolysin A*exeG*Scaffold314,115--14,54697.2General secretion pathway protein G*exeE*Scaffold315,920--17,42596.2General secretory pathway protein E*tapT*Scaffold849088--10,04495.9Twitching ATPase*hutZ*Scaffold2028,013--28,57095.7Heme iron utilization protein*exeF*Scaffold314,698--15,91895.6General secretion pathway protein F*tapB*Scaffold45118--109895.3Type IV-A pilus assembly ATPase PilB*exeI*Scaffold313,085--13,42994.7General secretion pathway protein I*hutC*Scaffold2030,092--31,12094.4ABC-type hemin transporter, permease protein*tapB*Scaffold28885--87094.4Type IV pilus assembly protein TapB*fleR/flrC*Scaffold1482516--385093.5Transcriptional activator*amoA*Scaffold860,005--61,17792.9Isochorismate synthases*tapW*Scaffold2528,637--29,75892.8Tfp pilus assembly protein, ATPase PilU*tapC*Scaffold451211--246792.5Type 4 fimbrial assembly protein PilC*flrB*Scaffold1481411--244592.2Two-component system flagellar sensor histidine kinase FlrB[^4] Table 4Distribution of the PHI Genes in *Aeromonas caviae* Strain SCAc2001^a^Gene NameScaffoldPosition in ScaffoldIdentity(%)PHI-Base AccessionDisease NameGene Function*csrA*Scaffold191661--184996.6PHI:5061Diarrheal diseasesSmall RNA-binding protein involved in the regulation of a wide range of cellular processes.*lrp*Scaffold10612,874--13,14392.1PHI:6497No data foundGlobal transcription factor*crp*Scaffold2014,048--14,68689.6PHI:2684Food poisoningRegulators of systemic infection*iscU*Scaffold2219,716--20,09985.6PHI:6892SalmonellosisFe-S cluster sensor*arcA*Scaffold2411,882--12,60184.8PHI:6532MeningitisAerobic respiration control protein*metJ*Scaffold361313--163683.2PHI:2695Blackleg diseaseRepressor of the methionine biosynthesis regulon*pykF*Scaffold517554--897882.8PHI:3134Gut-associated diseases; diarrhoea; enteritis; colitisPart of the pyruvate - tricarboxylic acid cycle node*lon*Scaffold6814,376--16,73082.6PHI:7160Fire blightProtease*dksA*Scaffold4012,676--13,05981.7PHI:6508SalmonellosisResponse Regulator*fur*Scaffold49144--57281.7PHI:4887Urinary tract infectionsglobal ferric uptake regulator*greB*Scaffold83192--66581.5PHI:7131SalmonellosisTranscription elongation factor*hfq*Scaffold2723,382--23,57081.1PHI:4064Pneumonic plagueRNA-binding protein

The Genetic Context of the Resistance Genes {#S0003-S2004}
-------------------------------------------

﻿Silicon analysis showed that the resistance gene *bla*~KPC-2~ was located in scaffold72 ﻿and that it also carried the ESBL gene *bla*~TEM-1~. Sequence analysis showed that scaffold72 had 68%, 59% and 59% query cover and 99.95%, 99.98% and 99.98% sequence similarities with plasmid pGSH8M-1-2 (AP019197),[@CIT0032] plasmid p1713-KPC (MH624132) and plasmid p198-KPC (MH624131) at nucleotide level, respectively. The linear structure of this genetic context is repA-orf-*klcA-korC-IS*Kpn6-*bla*~KPC~-*bla*~TEM~-*IS*Kpn27. However, the other sequence of scaffold72 was unique to *Aeromonas caviae* strain ScAc2001. The colistin resistance gene *mcr-3.3* was located in the scaffold216. Scaffold216 had 81%, 81% and 78% query cover and 99.89%, 99.06%, and 98.29% sequence similarities with the plasmid pGSH8M-1-2 (AP019197), *Aeromonas* ASNIH7 chromosome genome (CP026226), *Aeromonas veronii* 17ISAe chromosome genome (CP028133) at nucleotide level, respectively. The result showed the *mcr-3.3* carrying scaffold maybe derive from the plasmid and *Aeromonas* chromosome genome. In any case, the plasmid or chromosome borne colistin resistance gene *mcr* carried by the carbapenem-resistant -microorganisms is a risk factor in clinical control.

The ESBLs gene *bla*~CTX-M-14~ carrying scaffold180 had 100%, 98% and 98% query cover and 100%, 99.96% and 99.95% sequence similarities with the *Vibrio* Vb0624 chromosome genome (CP041202), plasmid pKP96 (EU195449)[@CIT0034] and plasmid pEC224_4 (CP018944) at nucleotide level, respectively. Scaffold231 carried ﻿four resistance genes (*catB3, bla*~OXA-10~, *aadA1* and *aac(6ʹ)-Ib3*). Sequence analysis showed that scaffold231 had 99%, 99% and 99% query cover and 99.97%, 99.97% and 99.97% sequence similarities with the plasmid pC45_002 (CP042553), plasmid pE33_002 (CP042519) and plasmid pEC224_4 (CP042480) at nucleotide level, respectively. It speculated that scaffold231 was derived from the plasmid.

The ESBLs gene *bla*~MOX-6~ was carried by the scaffold128. Sequence analysis showed that scaffold128 had 99%, 98% and 98% query cover and 98.3%, 98.17% and 98.15% sequence similarities with the *Aeromonas caviae* GSH8M-1 complete genome (AP019195.1),[@CIT0032] *Aeromonas caviae* strain T25-39 chromosome genome (CP025706.1) and *Aeromonas*strain R25-2 chromosome genome (CP025777.1) at nucleotide level, respectively.

Scaffold165 carried one class D β-lactamases (CHDLs) resistance gene *bla*~OXA-427~. Sequence analysis showed that scaffold165 had 98%, 98%, and 95% query cover and 95.83%, 95.83% and 95.67% sequence similarities with the *Aeromonas caviae* R25-2 genome (CP025777.1), *Aeromonas caviae* strain T25-39 genome (CP025706) and *Aeromonas caviae* GSH8M-1 genome (AP019195.1) at nucleotide level, respectively. This result showed th﻿at the resistance gene *bla*~OXA-427~ is chromosome borne. Another resistance gene *bla*~VEB-3~ was carried by the scaffold240. Sequence analysis showed that scaffold240 had 90% and 90% query cover and 99.96% and 99.95% sequence similarities with *Aeromonas hydrophila* strain MX16A genome (CP018201) and JM45 plasmid p1 (CP006657.1) at nucleotide level, respectively. The context genetic of this resistance gene is the *Int*1-*bla*~VEB-3~-*IS*600-*IS*26. These results indicated co-carriage of a large number of resistance genes in genome making *Aeromonas caviae* strain highly resistant to almost all kinds of commonly used antibiotics, and brings a serious challenge for resistance control and clinical treatment.

Characterization of the Genomic Islands and Prophages {#S0003-S2005}
-----------------------------------------------------

As shown in [Table 5](#T0005){ref-type="table"}, four genomic islands, named GI_SCAc2001-1 to GI_SCAc2001-4, were identified by the software IslandPATH-DIMOB, IslandPick, and SIGI-HMM. ﻿Silicon analysis showed that the length of the ﻿four genomic islands were 7,182, 6,950, 8,349 and 7,175bp with the G+C context of 54.585%, 63.425%, 62.275% and 62.45%, respectively. The sequences of ﻿four genomic islands are all the closest match to the *Aeromonas sp*. chromosome genome sequence in genbank. A total of ﻿eight prophages (lengthen\>2kbp), named Pp_SCAc2001-1 to Pp_SCAc2001-8, were identified by phiSpy. The size of the ﻿eight prophages ranged from 2823bp to 18,093bp with the average G+C content of 46.94%-65.37%, respectively. Among them, one of the prophage sequences\' closest match was the corresponding region of plasmid pMCR5_045096 and ﻿seven of the prophages were the closest match to the *Aeromonas sp*. chromosome genome in genbank. This indicated that the mobile genetic elements (genomic islands and prophages) can be excised and integrated from the chromosome and mobile genetic elements into each other. However, ﻿no resistance genes ﻿or virulence genes w﻿ere found in the genomic islands and prophages. To the best of our knowledge, the mobile genetic elements (including the genomic islands and prophages) are effective integrative elements in bacterial evolution including the resistance, virulence and some function genes.[@CIT0035]--[@CIT0037]Table 5Overall Features of the *Aeromonas caviae* SCAc2001 Genomic Islands and ProphagesGenomic Islands and ProphagesLocation (Start-End)Length (bp)G+C%Closest Match in Genbank (Query Cover and Identity)Genomic islandsGI_SCAc2001--1Scaffold26 (22,433--29,614)718254.58*Aeromonas sp*. ASNIH7 chromosome genome (74%,91.04%)GI_SCAc2001--2Scaffold42 (14,540--21,489)695063.42*Aeromonas*sp. ASNIH3 chromosome genome (100, 99.07%)GI_SCAc2001--3Scaffold57 (7135--15,483)834962.27*Aeromonas caviae*FDAARGOS_72 genome (98%, 99.19%)GI_SCAc2001--4Scaffold5 (42,875--50,049)717562.45*Aeromonas caviae*WCW1-2 genome (100%, 98.27%)ProphagesPp_SCAc2001--1Scaffold159 4884--7973309058.93plasmid pMCR5_045096 (100%, 100%)Pp_SCAc2001--2Scaffold158 413--7151673963.6*Aeromonas*sp. ASNIH2 chromosome genome (100%, 99.6%)Pp_SCAc2001--3Scaffold209 146--2968282361.18*Aeromonas caviae*GSH8M-1 genome (100%, 98.87%)Pp_SCAc2001--4Scaffold38 8991--27,08318,09365.37*Aeromonas sp*. ASNIH2 chromosome genome (98%, 97.62%)Pp_SCAc2001--5Scaffold202 221--4124390461.94*Aeromonas caviae* strain R25-6 genome (100%, 99%)Pp_SCAc2001--6Scaffold201 95--3149305546.94*Aeromonas media* WS genome (98%, 99.87%)Pp_SCAc2001--7Scaffold128 236--10,45010,21563.55*Aeromonas caviae* FDAARGOS_72 genome (100%, 98.47%)Pp_SCAc2001--8Scaffold129 479--4423394558.93*Aeromonas hydrophila* strain WCHAH045096 chromosome genome (80%, 94.6%)

Characterization of Secondary Metabolism Products Coding Clusters {#S0003-S2006}
-----------------------------------------------------------------

In this study, ﻿three secondary metabolism products coding clusters( nonribosomal peptide synthetases (nrps), hserlactone and bacteriocin), which are responsible for the biosynthesis of secondary metabolic products, were predicted using the search tool antiSMASH. ﻿The silicon analysis showed that the length of the ﻿three secondary metabolism coding clusters were 38,514, 17,438, and 9887 bp with the G+C context of 65.27%, 63.52% and 64.36%, respectively. Sequence analysis showed that the ﻿three putative gene clusters carrying 27, 13 and 12 ORFs, respectively ([Table 6](#T0006){ref-type="table"}). It's proved that ﻿a large number of pharmaceutical agents, microbial natural products including the sterigmatocystin (carcinogen), penicillin vancomycin and (antibiotic), lovastatin (antihypercholesterolemic agent), and cyclosporin A (anti-inflammatories and immunosuppressants) are synthesized by the diverse array of the secondary metabolism products coding clusters. Researching the characterization of secondary metabolism products coding clusters can be seen as one of the potential ways to research the new drugs.[@CIT0038]Table 6Characterization of Secondary Metabolism Products\' Coding ClustersCluster NameLocation (Start-End)Length (bp)G+C%ORF NumberPredicted ProteinnrpsScaffold8\
(25,698--64,211)38,51465.2727TerC family protein, AroG, AroA, SerC, FixB, FixA, FAD-binding protein, CorA, DUF2919 family protein, hypothetical protein, amonabactin ABC transporter permease subunit 2, Amonabactin ABC transporter permease subunit 1, Amonabactin ABC transporter ATP-binding protein, 4ʹ-phosphopantetheinyl transferase superfamily protein, ABC transporter substrate-binding protein, AmoH, AmoG, DhbA, AmoF, Isochorismatase family protein, EntE isochorismate synthase, Lipoprotein, hypothetical proteinhserlactoneScaffold70\
(246--17,682)17,43863.5213HldE, LpxL, bifunctional 2ʹ,3ʹ-cyclic-nucleotide 2ʹ-phosphodiesterase/3ʹ-nucleotidase, LysE family transporter, LuxR family transcriptional regulator, GNAT family N-acetyltransferase, ArgP/LysG family DNA-binding transcriptional, exoribonuclease II, PTS mannitol transporter subunit IICBA, mannitol-1-phosphate 5-dehydrogenase, MltR family transcriptional regulator, sodium:proton antiporter, hypothetical proteinbacteriocinScaffold139\
(89--9975)988764.3612Hypothetical protein, BCCT family transporter, DUF2282 domain-containing protein, DUF692 family protein, DUF2063 domain-containing protein, DoxX family protein, GNAT family N-acetyltransferase, PAS domain S-box protein, DUF3332 domain-containing protein, HD domain-containing protein

Conclusion {#S0004}
==========

Isolates of *Aeromonas caviae* ScAc2001 harboring a lot of resistance genes including the carbapenem-resistant gene *bla*~KPC~, colistin resistance gene *mcr-3.3* and other β-lactams, aminoglycosides, fluoroquinolones, phenicol resistance (*catB3*), sulfonamide and a variety of virulence factors, PHI genes, ﻿four genomic islands and ﻿eight prophages may result ﻿in a possible risk to public health.

Nucleotide Sequence Accession Numbers {#S0005}
=====================================

This Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank under the accession WUTZ00000000.1.

Ethical Statement {#S0006}
=================

This study was approved by the Experimentation Ethics Committee of Southwest Medical University.

Disclosure {#S0007}
==========

The authors report no conflicts of interest in this work.

[^1]: These authors contributed equally to this work

[^2]: **Notes:** ^a^The resistance genes were identified by the ResFinder ([<https://cge.cbs.dtu.dk/services/ResFinder/>]{.ul}) (minimum threshold for identity, 80%; minimum coverage, 60%).

[^3]: **Abbreviations:** N, Not shown.

[^4]: **Notes:** ^a^The resistance genes were identified by the virulence factors which were identified by the VFanalyzer ([<http://www.mgc.ac.cn/VFs/main.htm>]{.ul}).
